feed,title,long_url,short_url
InsiderMonkey,BofA Raises Thermo Fisher (TMO) Target as Biopharma Recovery Comes Into View,https://insidermonkey.com/blog/--1668403,
InsiderMonkey,Eli Lilly (LLY) Moves Fast to Secure Lead in India’s Obesity Drug Market,https://insidermonkey.com/blog/--1668402,
InsiderMonkey,Johnson & Johnson (JNJ) Ends Mid-Stage Eczema Study After Missing Efficacy Bar,https://insidermonkey.com/blog/--1668401,
InsiderMonkey,BofA Cuts AbbVie (ABBV) Target While Maintaining Neutral View,https://insidermonkey.com/blog/--1668400,
InsiderMonkey,FDA Fast-Tracks Two Merck (MRK) Drugs With Blockbuster Potential,https://insidermonkey.com/blog/--1668399,
InsiderMonkey,Pfizer (PFE) Braces for Bumpy Years as Growth Pushed Out to 2029,https://insidermonkey.com/blog/--1668398,
InsiderMonkey,CVS Gets Higher Target as Bernstein Cites Management Confidence,https://insidermonkey.com/blog/--1668388,
InsiderMonkey,"Goldman Sachs Raises Bristol-Myers (BMY) Target, Keeps Neutral Rating",https://insidermonkey.com/blog/--1668387,
InsiderMonkey,McKesson (MCK) Gets Higher Target at Deutsche Bank Despite Planned Spin-Off,https://insidermonkey.com/blog/--1668386,
InsiderMonkey,"BofA Downgrades Zoetis (ZTS) to Neutral, Cuts Price Target",https://insidermonkey.com/blog/--1668385,
InsiderMonkey,Abbott (ABT) Wins FDA Approval for Volt PFA System in AFib Treatment,https://insidermonkey.com/blog/--1668384,
InsiderMonkey,Strong Results and Pipeline Momentum Power Amgen’s (AMGN) 2025 Rally,https://insidermonkey.com/blog/--1668383,
InsiderMonkey,Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs,https://insidermonkey.com/blog/--1668382,
InsiderMonkey,Barclays Initiates Viatris (VTRS) with Overweight as Pharma Sentiment Improves,https://insidermonkey.com/blog/--1668381,
